Erech Finance Cahalacha (XTAE:EFNC) ROCE % : -100.85% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Erech Finance Cahalacha's annualized ROCE % for the quarter that ended in Dec. 2023 was -100.85%.

Erech Finance Cahalacha ROCE % Historical Data

The historical data trend for Erech Finance Cahalacha's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha ROCE % Chart

Erech Finance Cahalacha Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-16.27

1.60

5.47

-49.52

-93.81

Erech Finance Cahalacha Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial													5.16	9.34	-133.75	-49.59	-100.85

Erech Finance Cahalacha ROCE % Calculation

Erech Finance Cahalacha's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17.479	/	( ( (69.148 - 40.533)	+	(23.472 - 14.823) )	/ 2 )
	=	-17.479	/	( (28.615	+	8.649)	/ 2 )
	=	-17.479	/	18.632
	=	-93.81 %

Erech Finance Cahalacha's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-20.116	/	( ( (47.412 - 16.167)	+	(23.472 - 14.823) )	/ 2 )
	=	-20.116	/	( ( 31.245	+	8.649 )	/ 2 )
	=	-20.116	/	19.947
	=	-100.85 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Erech Finance Cahalacha (XTAE:EFNC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Erech Finance Cahalacha ROCE % Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Erech Finance Cahalacha (XTAE:EFNC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yakov Eliav 5, Downtown, Jerusalem, ISR

Website

http://www.insuline-medical.com

Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha (XTAE:EFNC) Headlines

No Headlines